I think you are lowballing the target price with approval. Again the USFDA is gonna be last in line to approve - they just suck so bad at their mission - they are in it for the fees and job offers to approve things, they really don't give a rats azz if something could help people. its all about the process of fleecing small pharma.
But hey, you and Whala know more about the nuts and bolts of this as I'm just a hopeful investor.
Cosa To GIA. ( go it alone ) is a huge / expensive undertaking . Stock will probably drop if they announced that for X So far they have not announced any partners for the EU. I suspect they will try and negotiate with CSL Vifor who already have a well established cardio-renal sales force operating there . I'm hoping for a buyout before end of year JMO Kiwi
News 
Market Data 
Discover 
